Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway

BACKGROUND: As the representative of fenamic acids, an important group of NSAIDs, flufenamic acid (FFA) has been used for anti-inflammation and analgesia in the clinic. Recently, researches have focused on the role of some members of NSAIDs in promoting osteogenesis. However, little attention has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuenan, Li, Zheng, Liu, Hao, Zhu, Yuan, Xia, Dandan, Wang, Siyi, Gu, Ranli, Wu, Weiliang, Zhang, Ping, Liu, Yunsong, Zhou, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642517/
https://www.ncbi.nlm.nih.gov/pubmed/31324207
http://dx.doi.org/10.1186/s13287-019-1321-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642517/
https://www.ncbi.nlm.nih.gov/pubmed/31324207
http://dx.doi.org/10.1186/s13287-019-1321-y

Ejemplares similares